Expression of phospholipase D isozymes in scar and viable tissue in congestive heart failure due to myocardial infarction

Journal of Cellular and Molecular Medicine

Volumn 8, Issue 4, 2004, Pages 526-536

  Dent, Melissa R ^a   Singal, Tushi ^a   Dhalla, Naranjan S ^a   Tappia, Paramjit S ^b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Cardiac sarcolemma; Congestive heart failure; Myocardial infarction; Phospholipase D isozymes; Scar tissue

Indexed keywords

GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ISOPROTEIN; LIPID; MESSENGER RNA; PHOSPHATIDIC ACID; PHOSPHOLIPASE D; RNA;

ANIMAL; ARTICLE; BODY WEIGHT; CHEMISTRY; CONGESTIVE HEART FAILURE; ENZYMOLOGY; HEART INFARCTION; HEART MUSCLE; HEART VENTRICLE; HYDROLYSIS; MALE; METABOLISM; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CICATRIX; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HYDROLYSIS; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS;

EID: 16644384420     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2004.tb00477.x     Document Type: Article

References (51)

1. Panagia V., Ou C., Taira Y., Dai J., Dhalla N.S., Phospholipase D activity in subcellular membranes of rat ventricular myocardium, Biochim. Biophys. Acta., 1064: 242-250, 1991
2. Ye H., Wolf R.A., Kurz T., Corr P.B., Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes, Cardiovasc. Res. 28: 1828-1834, 1994
3. Sadoshima J., Izumo S., Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers, Circ. Res. 73: 424-438, 1993
4. 2+ to phosphatidic acid in diabetic rats, Can. J. Cardiol. 12: 1092-1098, 1996
5. Dhalla N.S., Xu Y-J., Sheu S-S., Tappia P.S., Panagia V., Phosphatidic acid: a potential signal transducer for cardiac hypertrophy, J. Mol. Cell. Cardiol. 29: 2865-2871, 1997
6. 2+ and cardiac contractile force, Am. J. Physiol. 271: H651-H659, 1996
7. Colley W.C., Sung T-C., Roll R., Jenco J., Hammond S.M., Altshuller Y., Bar-Sagi D., Morris A.J., Frohman M.A., Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization, Curr. Biol. 7: 191-201, 1997
8. Frohman M.A., Morris A.J., Phospholipase D structure and function, Chem. Phys. Lipids 98: 127-140, 1999
9. Lee T.G., Park J.B., Lee S.D., Hong S., Kim J.H., Kim Y., Yi K.S., Bae S., Hannun Y.A., Obeid L.M., Suh S.G., Ryu S.H., Phorbol myristate acetate-dependent association of protein kinase C α with phospholipase D1 in intact cells, Biochim. Biophys. Acta 1347:199-204, 1997
10. Kim J.H., Lee S.D., Han J.M., Lee T.G., Kim Y., Park J.B., Lambeth J.D., Suh P.G., Ryu S.H., Activation of phospholipase D1 by direct interaction with ADP-ribosylation factor 1 and Ra1A, FEBS Lett. 430: 231-235, 1998
11. Yamazaki M., Zhang Y., Watanabe H., Yokozeki T., Ohno S., Kaibuchi K., Shibata H., Mukai H., Ono Y., Frohman M.A., Kanaho Y., Interaction of the small G protein RhoA with the C terminus of human phospholipase D1, J. Biol. Chem. 274: 6035-6038, 1999
12. Hammond S.M., Jenco J.M., Nakashima S., Cadwallader K., Cook S., Nozawa Y., Frohman M.A., Morris A.J., Characterization of two alternately spliced forms of phospholipase D1: Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α, J. Biol. Chem. 272: 3860-3868, 1997
13. Sciorra V.A., Rudge S.A., Prestwich G.D., Frohman M.A., Engebrecht J., Morris A.J., Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes, EMBO J. 18: 5911-5921, 1999
14. Kim J.H., Kim Y., Lee S.D., Lopez I., Arnold R.S., Lambeth J.D., Suh P.G., Ryu S.H., Selective activation of phospholipase D2 by unsaturated fatty acids, FEBS Lett. 454: 42-46, 1999
15. Dai J., Williams S.A., Ziegelhoffer A., Panagia V., Structure-activity relationship of the effect of cis-unsaturated fatty acids on heart sarcolemmal phospholipase D activity, Prostagland. Leuk. Essent. Fatty Acids 52: 167-171, 1995
16. 2-mediated activation of phospholipase D in rat heart sarcolemma, J. Mol. Cell. Cardiol. 30: 1203-1214, 1998
17. Sarri E., Pardo R., Fensome-Green A., Cockcroft S., Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid, Biochem. J. 369:319-329, 2003
18. 2 localizes to sarcolemmal membranes and is inhibited by α-actinin in an ADP-ribosylation factor-reversible manner, J. Biol. Chem. 275: 21295-21301, 2000
19. Dhalla N.S., Dixon I.M.C., Beamish R.E., Biochemical basis of heart function and contractile failure, J. Appl. Cardiol. 6: 7-30, 1991
20. Tappia P.S., Yu C-H., DiNardo P., Pasricha A.K., Dhalla N.S., Panagia V., Depressed responsiveness of phospholipase C isozymes to phosphatidic acid in congestive heart failure, J. Mol. Cell. Cardiol. 33: 431-440, 2001
21. Yu C-H., Panagia V., Tappia P.S., Liu S.-Y., Takeda N., Dhalla N.S., Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure, Biochim. Biophys. Acta. 1584: 65-72, 2002
22. Ju H., Zhao S., Tappia P.S., Panagia V., Dixon I.M.C., Expression of Gqα and PLC-β in scar and border tissue in heart failure due to myocardial infarction, Circulation 97: 892-898, 1998
23. Tappia P.S., Liu S-Y., Shatadal S., Takeda N., Dhalla N.S., Panagia V., Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril, Am. J. Physiol. 277: H40-H49, 1999
24. 2 in postinfarct congestive heart failure, Am. J. Physiol. 280: C573-C580, 2001
25. Dent M.R., Dhalla N.S., Tappia P.S., Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload, Am. J. Physiol. 287: H719-H727, 2004
26. Fahimi-Vahid M., Gosau N., Michalek C., Han L., Jakobs K.H., Schmidt M., Roberts N., Avkiran M., Wieland T., Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin, J. Mol. Cell. Cardiol. 34: 441-453, 2002
27. + exchange in phospholipase D-treated sarcolemmal vesicles, Am. J. Physiol. 279: H1179-H1184, 2000
28. 2+ exchange in cardiac sarcolemmal vesicles by phospholipase D, J. Biol. Chem. 259: 16-19, 1984
29. Langer G.A., Rich T.L., Phospholipase D produces increased contractile force in rabbit ventricle muscle, Circ. Res. 56: 146-149, 1985
30. Knabb M.T., Rubio R., Berne R.M., Calcium-dependent atrial slow action potentials generated with phosphatidic acid or phospholipase D, Pflügers Arch. 401: 435-437, 1984
31. Dhalla N.S., Afzal N., Beamish R.E., Naimark B., Takeda N., Nagano M., Pathophysiology of cardiac dysfunction in congestive heart failure, Can. J. Physiol. 9: 873-887, 1993
32. 2+ - handling in infarct-induced heart failure in rats, Cardiovasc. Res. 44: 67-80, 1999
33. Sjaastad I., Bentzen J.G., Semb, S.O., Ilebekk A., Sejersted O.M., Reduced calcium tolerance in rat cardiomyocytes after myocardial infarction, Acta Physiol. Scand. 175: 261-269, 2002
34. Moraru I.I., Popescu L.M., Maulik N., Liu X., Das D.K., Phospholipase D signaling in ischemic heart, Biochim. Biophys. Acta. 1139: 148-154, 1992
35. Trifan O.C., Popescu L.M., Tosaki A., Cordis G., Das D.K., Ischemic preconditioning involves phospholipase D, Ann N Y Acad. Sci. 793: 485-488, 1996
36. Tosaki A., Maulik N., Cordis G., Trifan O.C., Popescu L.M., Das D.K., Ischemic preconditioning triggers phospholipase D signaling in rat heart, Am. J. Physiol. 273: H1860-H1866, 1997
37. 2, C and D activation during myocardial ischemia and reperfusion. Ann. NY Acad. Sci. 723: 328-332, 1994
38. Kasai T., Ohguchi K., Nakashima S., Ito Y., Naganawa T., Kondo N., Nozawa Y., Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells, J. Immunol. 161: 6469-6474, 1998
39. Yamakawa H., Banno Y., Nakashima S., Sawada M., Yamada J., Yoshimura S., Nishimura Y., Nozawa Y., Sakai N., Increased phospholipase D2 activity during hypoxia-induced death of PC12 cells: its possible antiapoptotic role, Neuroreport. 11: 3647-3650, 2000
40. Plevin R., Kellock N.A., Wakelam M.J., Wadsworth R., Regulation by hypoxia of endothelin-1 -stimulated phospholipase D activity in sheep pulmonary artery cultured smooth muscle cells, Br. J. Pharmacol. 112: 311-315, 1999
41. Popescu A.T., Vidulescu C., Stanciu C.L., Popescu B.O., Popescu L.M., Selective protection by phosphatidic acid against staurosporine-induced neuronal apoptosis, J. Cell. Mol. Med. 6: 433-438, 2002
42. Vidulescu C., Mironneau J., Mironneau C., Popescu L.M., Messenger molecules of the phospholipase signaling system have dual effects on vascular smooth muscle contraction, J. Cell. Mol. Med. 4: 196-206, 2000
43. 2 trigger and sustain contraction, while phospholipase D intermediates relaxation in noradrenaline-stimulated portal vein smooth muscle, J. Med. Biochem. 4: 22-31, 2000
44. Pfeffer M.A., Braunwald E., Ventricular remodeling after myocardial infarction: experimental observations and clinical implications, Circulation 81: 1161-1172, 1990
45. Weber K.T., Sun Y., Katwa L.C., Wound healing following myocardial infarction, Clin. Cardiol. 19: 447-455, 1996
46. Fishbein M.C., Maclean D., Maroko P.R., Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution, Am. J. Pathol. 90: 57-70, 1978
47. Hao J., Wang B., Jones S.C., Jassal D.S., Dixon I.M.C., Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro, Am. J. Physiol. 279: H3020-H3030, 2000
48. Wang B., Hao J., Jones S.C., Yee M.-Y., Roth J., Dixon I.M.C., Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart, Am. J. Physiol. 282: H1685-H1696, 2002
49. Xu Y-J., Chapman D., Dixon I.M.C., Sethi R., Guo X., Dhalla N.S., Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation, J. Cell. Mol. Med. 8: 85-92, 2004
50. Yamamoto K., Takahashi Y., Mano T., Sakata Y., Nishikawa N., Yoshida J., Oishi Y., Hori M., Miwa T., Inoue S., Masuyama T., N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism, Eur. Heart J. 25: 1221-9, 2004
51. Hodgkin M.N., Pettitt T.R., Martin A., Michell R.H., Pemberton A.J., Wakelam M.J.O., Diacylglycerols and phosphatidates: which molecular species are intracellular messengers? Trends Biochem. Sci. 23: 200-204, 1998